Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04537416 · ClinicalTrials.gov registry record

Fertility, Hypercoagulability, and Inflammation (FREYA) Registry

A clinical trial of Thrombophilia, sponsored by Brigham and Women's Hospital.

Active
Registry status
1,000
Enrollment target
1
Study location

NCT04537416 is a study of Thrombophilia that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04537416, a study of Thrombophilia, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

A PubMed search of "thrombophilia" and "infertility" yields only 98 articles, the majority found in foreign medical journals and subspecialty journals with narrow readerships. Outside of Assisted Reproduction Clinics at academic medical centers, health care providers have limited awareness of the literature supporting thrombophilia evaluation and treatment in patients with recurrent pregnancy loss. As a result, women may suffer through years of repeated miscarriages before a thrombophilia evaluation is performed. By the time thrombophilia has been diagnosed as the cause of recurrent pregnancy loss, couples have often exhausted their personal savings on costly assisted reproductive therapies and present frustrated and psychologically exhausted. In this study, we will evaluate the frequency of thrombophilia as a cause of recurrent pregnancy loss and provide insights into our patient care experience at BWH.

Conditions Studied

Interventions

  • OTHER No intervention

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2018-04-01
Est. Completion 2026-12-31

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT04537416

The ClinicalTrials.gov registry entry for NCT04537416 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thrombophilia appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT04537416 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04537416 about?

NCT04537416 is a clinical study titled "Fertility, Hypercoagulability, and Inflammation (FREYA) Registry". A PubMed search of "thrombophilia" and "infertility" yields only 98 articles, the majority found in foreign medical journals and subspecialty journals with narrow readerships. Outside of Assisted Reproduction Clinics at academic medical centers, health care providers have limited awareness of the li...

What is the current status of trial NCT04537416?

This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2018-04-01. Estimated completion is 2026-12-31.

What conditions does trial NCT04537416 study?

This clinical trial studies the following conditions: Thrombophilia.

What interventions are being tested in trial NCT04537416?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT04537416?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04537416 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thrombophilia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.